Hôpital Roger Salengro

Lille, Hauts-de-France 59037

0 studies enrolling now · 1 studies all time

What they study most

Primary Mitochondrial Myopathy

Studies at this site

• An Efficacy and Safety Study of 24 Week Treatment With Mavodelpar (REN001) in Primary Mitochondrial Myopathy Patients — Completed